CrackitToday App

Prussian Blue Insoluble Formulations Drug

Prussian Blue Insoluble Formulations Drug:

A critical drug, ‘prussian blue’ insoluble formulations developed on a Defence Research and Development Organisation (DRDO) technology recently received approval from the Drugs Controller General of India (DCGI).

  • Prussian blue insoluble formulations is one of the critical medicines listed by the World Health Organisation for radiological and nuclear emergencies.
  • It was developed under the Technology Development Fund (TDF).
  • Technology Development Fund has been established to promote self-reliance in defense technology as a part of the ‘Make in India’ initiative.
  • The drug has been developed based on the technology of the Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, a laboratory of the DRDO.
  • The formulations are used for the decontamination of Cesium and Thallium.
  • The manufacturing and marketing licenses for the commercial use of the drug have been granted to Scott-Edil Pharmacia Limited, Himachal Pradesh, and Skanttr Lifescience, Gujarat, by DCGI.
  • The drug will be available under the trade name of Pru-DecorpTM and PruDecorp-MG.